glp 1 compound companies FDA Issues Warning Letters to 30 Telehealth Over Misleading Compounded GLP-1 RA Marketing Drugmakers battle pharmacies over compounded

Steven Gundry to explore how the gutbrain connection shapes mood, inflammation, and long-term health

What they found: Plasma NAD+ increased by 60 % in the NR arm Mild reduction of systolic blood pressure by 6 mmHg Improvement in arterial stiffness (markers of endothelial function) No effect on glycemia in the healthy population Excellent safety profile , no serious adverse events Why it matters: The study validated the oral bioavailability of NR and the ability to long-term increase the NAD+ pool in humans

Expanded use cases bring GLP-1 to unexpected therapy areas Originally created to help patients with type 2 diabetes manage their blood sugar, GLP-1 receptor agonists rose to fame after providers began prescribing them off-label for weight loss

It is mainly responsible for the absence of a necrotic core inside a growing melanoma in situ